CSF3 and colorectal cancer: We found that colorectal cancer mice treated with neutralizing anti-GCSF Abs showed reduced Neut/MDSCs in multiple compartments, and an increase in colon-resident B cells and CD8+ T cells, suggesting a favorable immune environment.